Visit vs PAP Compliance: 90% leak during therapy period

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Baseline	-	-	-	-	-	-	-	-
Final	81	53.5	± 13.1	51.8	27.3	111.3	220	301

Treatment Arm vs PAP Compliance: 90% leak during therapy period

Final

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Total	81	53.5	± 13.1	51.8	27.3	111.3	219	300
HLSE	-	-	-	-	-	-	100	100
HLSE-O	-	-	-	-	-	-	101	101
HLSE-P	81	53.5	± 13.1	51.8	27.3	111.3	18	99

Age vs PAP Compliance: 90% leak during therapy period

Final

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Total	81	53.5	± 13.1	51.8	27.3	111.3	219	300
45-54 years	14	56.2	± 11.7	58.2	36.5	82.5	35	49
55-64 years	39	50.7	± 11.4	50.3	27.3	77.8	88	127
65-74 years	27	56.3	± 15.7	55.3	32.3	111.3	92	119
75 or older	1	45.5	-	45.5	45.5	45.5	4	5

Gender vs PAP Compliance: 90% leak during therapy period

Final

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Total	81	53.5	± 13.1	51.8	27.3	111.3	220	301
Male	60	53.5	± 13.5	51.9	27.3	111.3	162	222
Female	21	53.2	± 12.3	50.9	36.0	77.8	58	79

Race vs PAP Compliance: 90% leak during therapy period

Final

	N	Mean	StdDev	Median	Min	Max	Unknown	Total
Total	81	53.5	± 13.1	51.8	27.3	111.3	219	300
African American or Black	5	49.7	± 10.9	45.9	36.2	64.6	35	40
Caucasian	68	54.4	± 13.6	53.0	27.3	111.3	169	237
Other	8	48.1	± 9.2	49.1	36.0	60.8	15	23

Heart Biomarker Evaluation in Apnea Treatment